Anlon Healthcare Limited has announced a television interview of its Managing Director as part of its regulatory disclosure obligations to stock exchanges.

Interview Details

The company has scheduled a TV interview featuring Mr. Punitkumar Rasadia, Managing Director of Anlon Healthcare Limited, with NDTV Profit. The interview is set to take place on Monday, April 27, 2026, at 1:30 PM.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified both BSE Limited and The National Stock Exchange of India Limited about this scheduled media interaction.

Content Guidelines

Anlon Healthcare Limited has emphasized that the discussion during the interview will be based exclusively on publicly available information and documents. The company has specifically stated that no unpublished price-sensitive information (UPSI) is proposed to be discussed during the interaction, ensuring compliance with regulatory guidelines.

Contingency Provisions

The company has noted that the interview may be cancelled, rescheduled, or postponed due to exigencies on the part of both parties. This standard disclaimer provides flexibility for both the company and the media organization in case of unforeseen circumstances.

The formal communication was digitally signed by Managing Director Punitkumar Rasadia on April 27, 2026, at 12:34:27 hours, demonstrating the company's commitment to timely regulatory disclosures.

Anlon healthcare Limited has successfully completed its bonus share allotment process, marking a significant milestone in the company's capital structure enhancement. The pharmaceutical company announced the completion of its 1:1 bonus equity share allotment on April 27, 2026, effectively doubling the shareholding for all eligible investors.

Bonus Share Allotment Details

The company's Board of Directors, in their meeting held on April 27, 2026, formalized the allotment of bonus equity shares to eligible shareholders. The allotment was executed with precision, targeting shareholders whose names appeared in the Register of Members and Register of Beneficial Owners as of the designated record date.

Impact on Share Capital Structure

The bonus share allotment has substantially transformed Anlon Healthcare's capital structure. The company has effectively doubled its equity base through this corporate action, providing existing shareholders with additional shares without any cash outflow.

Regulatory Compliance and Documentation

The bonus share allotment was conducted in full compliance with regulatory requirements under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had previously communicated with stakeholders through intimations dated March 6, 2026, April 8, 2026, and April 9, 2026, ensuring complete transparency throughout the process.

The formal documentation was signed by Punitkumar Rasadia, Managing Director (DIN: 06696258), with digital authentication completed on April 27, 2026, at 09:22:11 +05'30'. The efficient board meeting, lasting merely 15 minutes, demonstrates the company's streamlined decision-making processes and corporate governance standards.

Shareholder Benefits

Eligible shareholders who held shares as of April 24, 2026, have received one additional equity share for every share held, effectively doubling their shareholding in Anlon Healthcare Limited. This bonus issue enhances liquidity and makes shares more accessible to retail investors while maintaining proportional ownership rights for all existing shareholders.